ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 121 filers reported holding ANI PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 3.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,705,970 | +15.2% | 63,830 | +6.8% | 0.00% | 0.0% |
| Q2 2023 | $3,218,119 | +456.2% | 59,783 | +310.4% | 0.00% | – |
| Q1 2023 | $578,641 | +134.9% | 14,568 | +137.9% | 0.00% | – |
| Q4 2022 | $246,328 | -13.3% | 6,123 | -30.8% | 0.00% | – |
| Q3 2022 | $284,000 | -88.0% | 8,851 | -88.9% | 0.00% | -100.0% |
| Q2 2022 | $2,374,000 | +310.7% | 80,016 | +288.7% | 0.00% | – |
| Q1 2022 | $578,000 | -74.8% | 20,588 | -58.7% | 0.00% | – |
| Q4 2021 | $2,296,000 | +34.9% | 49,826 | -4.0% | 0.00% | – |
| Q3 2021 | $1,702,000 | +3.9% | 51,886 | +11.1% | 0.00% | – |
| Q2 2021 | $1,638,000 | -8.1% | 46,709 | -5.3% | 0.00% | – |
| Q1 2021 | $1,782,000 | -9.5% | 49,309 | -27.3% | 0.00% | -100.0% |
| Q4 2020 | $1,970,000 | +117.7% | 67,837 | +111.4% | 0.00% | – |
| Q3 2020 | $905,000 | -13.8% | 32,084 | +24.6% | 0.00% | – |
| Q1 2020 | $1,050,000 | -21.1% | 25,756 | +19.4% | 0.00% | – |
| Q4 2019 | $1,330,000 | +21.7% | 21,565 | +43.8% | 0.00% | – |
| Q3 2019 | $1,093,000 | -56.0% | 15,000 | -50.4% | 0.00% | -100.0% |
| Q2 2019 | $2,484,000 | -4.5% | 30,220 | -18.0% | 0.00% | – |
| Q1 2019 | $2,600,000 | +142.5% | 36,845 | +54.7% | 0.00% | – |
| Q4 2018 | $1,072,000 | -42.9% | 23,821 | -28.2% | 0.00% | – |
| Q3 2018 | $1,877,000 | +84.7% | 33,187 | +118.3% | 0.00% | – |
| Q2 2018 | $1,016,000 | -61.4% | 15,200 | -66.4% | 0.00% | -100.0% |
| Q1 2018 | $2,631,000 | +7.4% | 45,203 | +19.0% | 0.00% | 0.0% |
| Q4 2017 | $2,449,000 | +51.5% | 37,994 | +23.4% | 0.00% | 0.0% |
| Q3 2017 | $1,616,000 | +17.0% | 30,778 | +4.3% | 0.00% | 0.0% |
| Q2 2017 | $1,381,000 | +97.0% | 29,516 | +108.3% | 0.00% | – |
| Q1 2017 | $701,000 | -58.9% | 14,169 | -49.6% | 0.00% | -100.0% |
| Q4 2016 | $1,704,000 | -52.0% | 28,100 | -47.5% | 0.00% | -33.3% |
| Q3 2016 | $3,551,000 | +611.6% | 53,513 | +498.4% | 0.00% | +200.0% |
| Q2 2016 | $499,000 | -50.1% | 8,942 | -64.7% | 0.00% | 0.0% |
| Q3 2015 | $1,001,000 | +193.5% | 25,337 | +364.3% | 0.00% | – |
| Q1 2015 | $341,000 | -2.0% | 5,457 | -11.4% | 0.00% | – |
| Q4 2014 | $348,000 | +13.4% | 6,161 | -43.4% | 0.00% | – |
| Q3 2014 | $307,000 | -48.7% | 10,877 | -37.4% | 0.00% | -100.0% |
| Q2 2014 | $599,000 | +21.7% | 17,377 | +10.7% | 0.00% | 0.0% |
| Q1 2014 | $492,000 | – | 15,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 367,754 | $10,911,000 | 4.08% |
| AIGH Capital Management LLC | 244,500 | $7,254,000 | 1.91% |
| Parkman Healthcare Partners LLC | 108,559 | $3,221,000 | 1.19% |
| Worth Venture Partners, LLC | 60,831 | $1,927,000 | 1.13% |
| Global Alpha Capital Management Ltd. | 323,731 | $9,605,000 | 1.04% |
| Mesirow Financial Investment Management, Inc. | 6,892 | $204,000 | 0.99% |
| MARATHON CAPITAL MANAGEMENT | 74,460 | $2,209,000 | 0.71% |
| EMERALD ADVISERS, LLC | 455,880 | $13,526,000 | 0.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 356,865 | $10,588,000 | 0.61% |
| Jackson Creek Investment Advisors LLC | 32,698 | $1,120,000 | 0.45% |